These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9740951)

  • 1. Update in glaucoma: the new pharmacotherapies. Dorzolamide hydrochloride.
    Gould LF
    Can J Ophthalmol; 1998 Aug; 33(5):253-4; discussion 257-8. PubMed ID: 9740951
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial assessing dorzolamide in patients with glaucoma who are younger than 6 years.
    Ott EZ; Mills MD; Arango S; Getson AJ; Assaid CA; Adamsons IA
    Arch Ophthalmol; 2005 Sep; 123(9):1177-86. PubMed ID: 16157797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bimatoprost versus timolol and dorzolamide.
    Tressler CS
    Ophthalmology; 2005 Feb; 112(2):357-8; author reply 358-9. PubMed ID: 15691575
    [No Abstract]   [Full Text] [Related]  

  • 4. [The hypotensive action and side effects of the carboanhydrase inhibitor dorzolamide hydrochloride].
    Egorov AE
    Vestn Oftalmol; 1996; 112(2):3-4. PubMed ID: 9045485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful pressure decrease and improved patient quality of life by Trusopt].
    Prell R
    Klin Monbl Augenheilkd; 1996 Apr; 208(4):11-2. PubMed ID: 8778487
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients.
    Sakai H; Shinjyo S; Nakamura Y; Nakamura Y; Ishikawa S; Sawaguchi S
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):483-9. PubMed ID: 16386090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Azarga, a new and useful fixed combination in glaucoma treatment].
    Călugăru M; Călugăru D
    Oftalmologia; 2011; 55(3):38-46. PubMed ID: 22428291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Local carbonic anhydrase inhibitor dorzolamide: development and properties].
    Pfeiffer N
    Ophthalmologe; 1996 Feb; 93(1):103-18. PubMed ID: 8867167
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and tolerability of preservative-free eye drops containing a fixed combination of dorzolamide and timolol in glaucoma patients.
    Renieri G; Führer K; Scheithe K; Lorenz K; Pfeiffer N; Thieme H
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):597-603. PubMed ID: 20977366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of dorzolamide as added therapy in glaucoma patients with maximum tolerated drug therapy. A pilot study].
    Denk PO; Knorr M; Kriegerowski M; Thiel HJ
    Klin Monbl Augenheilkd; 1997 Jun; 210(6):360-4. PubMed ID: 9333661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin eruption and thrombocytopaenia in a woman with glaucoma: a case report.
    Santos VM; Castro RA; Lima CC; Moraes MB; Sugai TA
    West Indian Med J; 2010 Jan; 59(1):102-5. PubMed ID: 20931926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotony and choroidal effusion induced by topical timolol and dorzolamide in patients with previous glaucoma drainage device implantation.
    Callahan C; Ayyala RS
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):467-9. PubMed ID: 14620750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-combination brimonidine/timolol as adjunctive therapy to a prostaglandin analog: a 3-month, open-label, replacement study in glaucoma patients.
    Nguyen QH; Earl M
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):541-4. PubMed ID: 20028261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update in glaucoma: the new pharmacotherapies. Latanoprost.
    Buys YM
    Can J Ophthalmol; 1998 Aug; 33(5):255-7; discussion 257-8. PubMed ID: 9740953
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops.
    Flórez A; Rosón E; Conde A; González B; García-Doval I; de la Torre C; Cruces M
    J Am Acad Dermatol; 2005 Nov; 53(5):909-11. PubMed ID: 16243161
    [No Abstract]   [Full Text] [Related]  

  • 19. New topical medications in the treatment of glaucoma.
    Gandham SB
    J Ophthalmic Nurs Technol; 1997; 16(6):290-1. PubMed ID: 9460417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of an intraocular implant for glaucoma treatment.
    Natu MV; Gaspar MN; Fontes Ribeiro CA; Cabrita AM; de Sousa HC; Gil MH
    Int J Pharm; 2011 Aug; 415(1-2):73-82. PubMed ID: 21641984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.